Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2018

Open Access 01-09-2018 | Original Article

Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey

Authors: Tom Stargardt, Christian Eckmann, Emilio Bouza, Gian Maria Rossolini, Paolo Antonio Grossi

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2018

Login to get access

Abstract

To explore the attitudes of European physicians on adherence and how treatment modalities impact adherence in complicated forms of soft skin and skin structure infections, now referred as acute bacterial skin and skin structures infections (ABSSSI). After literature review, a questionnaire was prepared. Topics focused on (1) the importance of adherence, (2) the importance of administration regimen on adherence, (3) the importance of drug selection on adherence, (4) the importance of complexity on choice of drug for treatment, (5) the role of adherence in drug resistance, and (6) the role of adherence in administration of long-acting antibiotics (ABs). The questionnaire was administered to 323 European infectious diseases specialists, of whom 74% responded. A modified Delphi method was used to obtain the highest consensus. Results varied by countries. We found a high degree of agreement of the importance of adherence in ABSSSI treatment. Experts agreed that complexity of patient’s conditions, drug selection, drug resistance, the type of regimen, and the number of infusions impact adherence. Two items linking oral switching and adherence did not reach consensus. Adherence for ABSSSI therapies appears a crucial factor for therapeutic management and reduces the risk of AB resistance. Among new treatment opportunities, long-acting agents, with their characteristics, may represent an interesting options.
Appendix
Available only for authorised users
Literature
1.
go back to reference Russo A, Concia E, Cristini F, De Rosa FG, Esposito S, Menichetti F, Petrosillo N, Tumbarello M, Venditti M, Viale P, Viscoli C, Bassetti M (2016) Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections. Clin Microbiol Infect 22(Suppl 2):S27–S36CrossRefPubMed Russo A, Concia E, Cristini F, De Rosa FG, Esposito S, Menichetti F, Petrosillo N, Tumbarello M, Venditti M, Viale P, Viscoli C, Bassetti M (2016) Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections. Clin Microbiol Infect 22(Suppl 2):S27–S36CrossRefPubMed
2.
go back to reference Nathwani D, Dryden M, Garau J (2016) Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe. Int J Antimicrob Agents 48(2):127–136CrossRefPubMed Nathwani D, Dryden M, Garau J (2016) Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe. Int J Antimicrob Agents 48(2):127–136CrossRefPubMed
3.
go back to reference Tran MC, Naumovski S, Goldstein EJ (2015) The times they are a-changin’: new antibacterials for skin and skin structure infections. Am J Clin Dermatol 16(3):137–146CrossRefPubMed Tran MC, Naumovski S, Goldstein EJ (2015) The times they are a-changin’: new antibacterials for skin and skin structure infections. Am J Clin Dermatol 16(3):137–146CrossRefPubMed
5.
go back to reference Vrijens B, Urquhart J (2005) Patient adherence to prescribed antimicrobial drug dosing regimens. J Antimicrob Chemother 55(5):616–627CrossRefPubMed Vrijens B, Urquhart J (2005) Patient adherence to prescribed antimicrobial drug dosing regimens. J Antimicrob Chemother 55(5):616–627CrossRefPubMed
6.
go back to reference Eells SJ, Nguyen M, Jung J, Macias-Gil R, May L, Miller LG (2016) The relationship between adherence to oral antibiotics and post-discharge clinical outcomes among patients hospitalized with Staphylococcus aureus skin infections. Antimicrob Agents Chemother Eells SJ, Nguyen M, Jung J, Macias-Gil R, May L, Miller LG (2016) The relationship between adherence to oral antibiotics and post-discharge clinical outcomes among patients hospitalized with Staphylococcus aureus skin infections. Antimicrob Agents Chemother
7.
go back to reference Dryden M, Andrasevic AT, Bassetti M, Bouza E, Chastre J, Cornaglia G, Esposito S, French G, Giamarellou H, Gyssens IC, Nathwani D, Unal S, Voss A (2010) A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice. Clin Microbiol Infect 16(Suppl 1):3–30CrossRefPubMed Dryden M, Andrasevic AT, Bassetti M, Bouza E, Chastre J, Cornaglia G, Esposito S, French G, Giamarellou H, Gyssens IC, Nathwani D, Unal S, Voss A (2010) A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice. Clin Microbiol Infect 16(Suppl 1):3–30CrossRefPubMed
8.
go back to reference Moran GJ, Fang E, Corey GR, Das AF, De Anda C, Prokocimer P (2014) Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial. Lancet Infect Dis 14(8):696–705CrossRefPubMed Moran GJ, Fang E, Corey GR, Das AF, De Anda C, Prokocimer P (2014) Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial. Lancet Infect Dis 14(8):696–705CrossRefPubMed
9.
go back to reference Nathwani D, Eckmann C, Lawson W, Solem CT, Corman S, Stephens JM, Macahilig C, Simoneau D, Chambers R, Li JZ, Haider S (2014) Influence of real-world characteristics on outcomes for patients with methicillin-resistant staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe. BMC Infect Dis 14:476CrossRefPubMedPubMedCentral Nathwani D, Eckmann C, Lawson W, Solem CT, Corman S, Stephens JM, Macahilig C, Simoneau D, Chambers R, Li JZ, Haider S (2014) Influence of real-world characteristics on outcomes for patients with methicillin-resistant staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe. BMC Infect Dis 14:476CrossRefPubMedPubMedCentral
10.
go back to reference Montravers P, Snauwaert A, Welsch C (2016) Current guidelines and recommendations for the management of skin and soft tissue infections. Curr Opin Infect Dis 29(2):131–138CrossRefPubMed Montravers P, Snauwaert A, Welsch C (2016) Current guidelines and recommendations for the management of skin and soft tissue infections. Curr Opin Infect Dis 29(2):131–138CrossRefPubMed
11.
go back to reference Anastasio PJ, Wolthoff P, Galli A, Fan W (2017) Single-dose Oritavancin compared to standard of care IV antibiotics for acute bacterial skin and skin structure infection in the outpatient setting: a retrospective real-world study. Infect Dis Ther 6(1):115–128CrossRefPubMedPubMedCentral Anastasio PJ, Wolthoff P, Galli A, Fan W (2017) Single-dose Oritavancin compared to standard of care IV antibiotics for acute bacterial skin and skin structure infection in the outpatient setting: a retrospective real-world study. Infect Dis Ther 6(1):115–128CrossRefPubMedPubMedCentral
12.
go back to reference Esposito S, Noviello S, Leone S (2015) Dalbavancin for the treatment of acute bacterial skin and skin structure infections. Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 23(4):313–317 Esposito S, Noviello S, Leone S (2015) Dalbavancin for the treatment of acute bacterial skin and skin structure infections. Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 23(4):313–317
13.
go back to reference Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC (2014) Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis 59(2):147–159CrossRefPubMed Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC (2014) Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis 59(2):147–159CrossRefPubMed
14.
go back to reference Dalkey NB, Brown BB, Cochran, S. (1969) The Delphi Method, III: Use of self ratings to improve group estimates Dalkey NB, Brown BB, Cochran, S. (1969) The Delphi Method, III: Use of self ratings to improve group estimates
15.
go back to reference Eells SJ, Nguyen M, Jung J, Macias-Gil R, May L, Miller LG (2016) Relationship between adherence to oral antibiotics and Postdischarge clinical outcomes among patients hospitalized with Staphylococcus aureus skin infections. Antimicrob Agents Chemother 60(5):2941–2948CrossRefPubMedPubMedCentral Eells SJ, Nguyen M, Jung J, Macias-Gil R, May L, Miller LG (2016) Relationship between adherence to oral antibiotics and Postdischarge clinical outcomes among patients hospitalized with Staphylococcus aureus skin infections. Antimicrob Agents Chemother 60(5):2941–2948CrossRefPubMedPubMedCentral
16.
go back to reference Esposito S, Leone S, Noviello S, Ianniello F (2004) Management of severe bacterial infections and role of the infectious disease specialist: results of an interview-based survey. Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 12(2):90–100 Esposito S, Leone S, Noviello S, Ianniello F (2004) Management of severe bacterial infections and role of the infectious disease specialist: results of an interview-based survey. Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 12(2):90–100
17.
go back to reference Marra CA, Frighetto L, Goodfellow AF, Wai AO, Chase ML, Nicol RE, Leong CA, Tomlinson S, Ferreira BM, Jewesson PJ (2005) Willingness to pay to assess patient preferences for therapy in a Canadian setting. BMC Health Serv Res 5:43CrossRefPubMedPubMedCentral Marra CA, Frighetto L, Goodfellow AF, Wai AO, Chase ML, Nicol RE, Leong CA, Tomlinson S, Ferreira BM, Jewesson PJ (2005) Willingness to pay to assess patient preferences for therapy in a Canadian setting. BMC Health Serv Res 5:43CrossRefPubMedPubMedCentral
18.
go back to reference Esposito S, Noviello S, Boccia G, De Simone G, Pagliano P, De Caro F (2016) Changing modalities of outpatient parenteral antimicrobial therapy use over time in Italy: a comparison of two time periods. Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 24(2):137–139 Esposito S, Noviello S, Boccia G, De Simone G, Pagliano P, De Caro F (2016) Changing modalities of outpatient parenteral antimicrobial therapy use over time in Italy: a comparison of two time periods. Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 24(2):137–139
19.
go back to reference Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, Kumar N, Downing M, Pettibone S, Hoagland R, Eells SJ, Boyle MG, Parker TC, Chambers HF (2017) A placebo-controlled trial of antibiotics for smaller skin abscesses. N Engl J Med 376(26):2545–2555CrossRefPubMed Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, Kumar N, Downing M, Pettibone S, Hoagland R, Eells SJ, Boyle MG, Parker TC, Chambers HF (2017) A placebo-controlled trial of antibiotics for smaller skin abscesses. N Engl J Med 376(26):2545–2555CrossRefPubMed
20.
go back to reference Talan DA, Mower WR, Krishnadasan A, Abrahamian FM, Lovecchio F, Karras DJ, Steele MT, Rothman RE, Hoagland R, Moran GJ (2016) Trimethoprim–sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med 374(9):823–832CrossRefPubMedPubMedCentral Talan DA, Mower WR, Krishnadasan A, Abrahamian FM, Lovecchio F, Karras DJ, Steele MT, Rothman RE, Hoagland R, Moran GJ (2016) Trimethoprim–sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med 374(9):823–832CrossRefPubMedPubMedCentral
21.
go back to reference Eckmann C, Lawson W, Nathwani D, Solem CT, Stephens JM, Macahilig C, Simoneau D, Hajek P, Charbonneau C, Chambers R, Li JZ, Haider S (2014) Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria. Int J Antimicrob Agents 44(1):56–64CrossRefPubMed Eckmann C, Lawson W, Nathwani D, Solem CT, Stephens JM, Macahilig C, Simoneau D, Hajek P, Charbonneau C, Chambers R, Li JZ, Haider S (2014) Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria. Int J Antimicrob Agents 44(1):56–64CrossRefPubMed
22.
go back to reference Nathwani D, Lawson W, Dryden M, Stephens J, Corman S, Solem C, Li J, Charbonneau C, Baillon-Plot N, Haider S, Eckmann C (2015) Implementing criteria-based early switch/early discharge programmes: a European perspective. Clin Microbiol Infect 21(Suppl 2):S47–S55CrossRefPubMed Nathwani D, Lawson W, Dryden M, Stephens J, Corman S, Solem C, Li J, Charbonneau C, Baillon-Plot N, Haider S, Eckmann C (2015) Implementing criteria-based early switch/early discharge programmes: a European perspective. Clin Microbiol Infect 21(Suppl 2):S47–S55CrossRefPubMed
23.
go back to reference Boucher HW, Wilcox M, Talbot GH, Puttagunta S, Das AF, Dunne MW (2014) Once-weekly dalbavancin versus daily conventional therapy for skin infection. N Engl J Med 370(23):2169–2179CrossRefPubMed Boucher HW, Wilcox M, Talbot GH, Puttagunta S, Das AF, Dunne MW (2014) Once-weekly dalbavancin versus daily conventional therapy for skin infection. N Engl J Med 370(23):2169–2179CrossRefPubMed
24.
go back to reference Dunne MW, Puttagunta S, Giordano P, Krievins D, Zelasky M, Baldassarre J (2016) A randomized clinical trial of single-dose versus weekly Dalbavancin for treatment of acute bacterial skin and skin structure infection. Clin Infect Dis 62(5):545–551CrossRefPubMed Dunne MW, Puttagunta S, Giordano P, Krievins D, Zelasky M, Baldassarre J (2016) A randomized clinical trial of single-dose versus weekly Dalbavancin for treatment of acute bacterial skin and skin structure infection. Clin Infect Dis 62(5):545–551CrossRefPubMed
25.
go back to reference Corey GR, Good S, Jiang H, Moeck G, Wikler M, Green S, Manos P, Keech R, Singh R, Heller B, Bubnova N, O'Riordan W (2015) Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study. Clin Infect Dis 60(2):254–262CrossRefPubMed Corey GR, Good S, Jiang H, Moeck G, Wikler M, Green S, Manos P, Keech R, Singh R, Heller B, Bubnova N, O'Riordan W (2015) Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study. Clin Infect Dis 60(2):254–262CrossRefPubMed
26.
go back to reference Pulido-Cejudo A, Guzmán-Gutierrez M, Jalife-Montaño A, Ortiz-Covarrubias A, Martínez-Ordaz JL, Noyola-Villalobos HF, Hurtado-López LM (2017) Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure. Ther Adv Infect Dis 4(5):143–161PubMedPubMedCentral Pulido-Cejudo A, Guzmán-Gutierrez M, Jalife-Montaño A, Ortiz-Covarrubias A, Martínez-Ordaz JL, Noyola-Villalobos HF, Hurtado-López LM (2017) Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure. Ther Adv Infect Dis 4(5):143–161PubMedPubMedCentral
27.
go back to reference McBride D, Krekel T, Hsueh K, Durkin MJ (2017) Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections. Expert Opin Drug Metab Toxicol 13(3):331–337CrossRefPubMed McBride D, Krekel T, Hsueh K, Durkin MJ (2017) Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections. Expert Opin Drug Metab Toxicol 13(3):331–337CrossRefPubMed
28.
go back to reference Scott LJ (2015) Dalbavancin: a review in acute bacterial skin and skin structure infections. Drugs 75(11):1281–1291CrossRefPubMed Scott LJ (2015) Dalbavancin: a review in acute bacterial skin and skin structure infections. Drugs 75(11):1281–1291CrossRefPubMed
29.
go back to reference Syed YY, Scott LJ (2015) Oritavancin: a review in acute bacterial skin and skin structure infections. Drugs 75(16):1891–1902CrossRefPubMed Syed YY, Scott LJ (2015) Oritavancin: a review in acute bacterial skin and skin structure infections. Drugs 75(16):1891–1902CrossRefPubMed
30.
go back to reference Palmieri F, Alberici F, Deales A, Furneri G, Menichetti F, Orchi N, Quesada-Rodriguez C, Pilli S, Rapisarda F, Tassielli D, Tringali M, Esposito S, Ippolito G (2013) Early discharge of infectious disease patients: an opportunity or extra cost for the Italian healthcare system? Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 21(4):270–278 Palmieri F, Alberici F, Deales A, Furneri G, Menichetti F, Orchi N, Quesada-Rodriguez C, Pilli S, Rapisarda F, Tassielli D, Tringali M, Esposito S, Ippolito G (2013) Early discharge of infectious disease patients: an opportunity or extra cost for the Italian healthcare system? Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 21(4):270–278
Metadata
Title
Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey
Authors
Tom Stargardt
Christian Eckmann
Emilio Bouza
Gian Maria Rossolini
Paolo Antonio Grossi
Publication date
01-09-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2018
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3264-0

Other articles of this Issue 9/2018

European Journal of Clinical Microbiology & Infectious Diseases 9/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.